A randomized, double-blinded, placebo-controlled, single-center, comparative study evaluating Phaseolean® safety and efficacy in overweight/obese participants
| Autor: | Singh, Shashi Chandrama ⁎, Singh, Harshpal, Choudhary, Muskan |
|---|---|
| Zdroj: | In Heliyon 15 August 2024 10(15) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|